Nachrichten zur AngioDynamics Aktie

Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Heres is How to Trade

The consensus price target hints at a 94.3% upside potential for AngioDynamics (ANGO). While empirical research shows that this sought-after…

[Latest] Global Embolic Protection Device Market Size/Share Worth USD 3,562.2 Million by 2033 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE

AngioDynamics announces the receipt of CPT Category I code for IRE technology.…

AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise

AngioDynamics (ANGO) delivers decent top-line results on a pro-forma basis in first-quarter fiscal 2025, driven by strength in the Med…

AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript

…

AngioDynamics, Inc. 2025 Q1 - Results - Earnings Call Presentation

…

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe

AngioDynamics RECOVER-AV trial evaluates the AlphaVac F1885 Systems safety and efficacy in treating acute pulmonary embolism in Europe.…

Does AngioDynamics (ANGO) Have the Potential to Rally 77.03% as Wall Street Analysts Expect?

The mean of analysts price targets for AngioDynamics (ANGO) points to a 77% upside in the stock. While this highly…

AngioDynamics: Lumpy Progress Is Still Progress

…

AngioDynamics (ANGO) Q4 Earnings Top Estimates, Gross Margin Down

AngioDynamics (ANGO) registers overall strong top-line results on a pro-forma basis in fourth-quarter fiscal 2024, driven by strength in the…

Earnings call: AngioDynamics sees steady growth in FY 2024 results By Investing.com

Earnings call: AngioDynamics sees steady growth in FY 2024 results…

AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript

…

AngioDynamics (ANGO) AlphaVac System Gets CE Mark Approval

AngioDynamics (ANGO) announces the European CE Mark approval of its AlphaVac F1885 System, which is likely to expand the range…

AngioDynamics: A Story To Monitor

…

Earnings call: AngioDynamics posts mixed Q3 results, focuses on growth By Investing.com

Earnings call: AngioDynamics posts mixed Q3 results, focuses on growth…

AngioDynamics (ANGO) AlphaVac Gets FDA Nod for PE Treatment

AngioDynamics (ANGO) announces the FDAs approval of its AlphaVac F1885 System, which is likely to expand the range of therapy…

AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates

Despite strength in the Med Tech business, AngioDynamics (ANGO) registers overall soft performance in third-quarter fiscal 2024.…

AngioDynamics (ANGO) Q3 2024 Earnings Call Transcript

…

AngioDynamics (ANGO) Settles Patent Litigations With BD

AngioDynamics (ANGO) announces its settlement agreement with BDs affiliate, C.R. Bard, to resolve a 10-year dispute over outstanding patent litigation.…

AngioDynamics sells PICC and Midline portfolios for $45 million By Investing.com

AngioDynamics sells PICC and Midline portfolios for $45 million…

AngioDynamics (ANGO) Stock Sinks As Market Gains: Heres Why

The latest trading day saw AngioDynamics (ANGO) settling at $6.09, representing a -0.98% change from its previous close.…

AngioDynamics (ANGO) New XL Catheter to Help in PAD Treatment

AngioDymics (ANGO) new FDA-approved Auryon XL Catheter is likely to boost PAD treatment by eliminating access site complications in Atherectomy…

AngioDynamics: Restructuring Initiative May Not Go Far Enough

…

Cardiac Ablation Market revenue to hit USD 5 Billion by 2035, says Research Nester

Leading cardiac ablation market players include Medtronic, AngioDynamics, Atricure, Inc., Alcon, Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Medical Device…

AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss

AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in second-quarter fiscal 2024.…

AngioDynamics, Inc. (ANGO) Q2 2024 Earnings Call Transcript

…

AngioDynamics, Inc. 2024 Q2 - Results - Earnings Call Presentation

…

AngioDynamics stock dives after sales miss, lowered full-year outlook

…

AngioDynamics (ANGO) Reports Q2 Loss, Misses Revenue Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of 44.44% and 3.15%, respectively, for the quarter ended November 2023. Do the…

AngioDynamics Q2 2024 Earnings Preview

…

Per-Encounter Medical Market is Booming and Expected to Reach USD 377.93 Billion by 2031 | Latest InsightAce Study

Companies covered in this study are Abbott, Cardinal Health, Johnson & Johnson, Medtronic, 3M, Steris, Catalent Inc., Smiths Medical Inc.,…

AngioDynamics (ANGO) Falls More Steeply Than Broader Market: What Investors Need to Know

AngioDynamics (ANGO) closed the most recent trading day at $6.77, moving -1.31% from the previous trading session.…

AngioDynamics (ANGO) Stock Slides as Market Rises: Facts to Know Before You Trade

In the most recent trading session, AngioDynamics (ANGO) closed at $6.74, indicating a -0.15% shift from the previous trading day.…

AngioDynamics (ANGO) Outperforms Broader Market: What You Need to Know

AngioDynamics (ANGO) closed the most recent trading day at $6.85, moving +1.33% from the previous trading session.…

AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, AngioDynamics (ANGO) closed at $6.86, marking a -1.15% move from the previous day.…

AngioDynamics: Quartalsergebnisse zum jüngsten Jahresviertel

AngioDynamics hat am 04.10.2023 die Geschäftsergebnisse zum jüngsten Jahresviertel vorgestellt.Das EPS lag bei -0,120 USD. Ein Jahr zuvor waren -0,060…

AngioDynamics, Inc. (ANGO) Q1 2024 Earnings Call Transcript

…

AngioDynamics (ANGO) Stock Sinks As Market Gains: What You Should Know

AngioDynamics (ANGO) closed the most recent trading day at $8.76, moving -1.35% from the previous trading session....…

AngioDynamics (ANGO) Flat As Market Sinks: What You Should Know

AngioDynamics (ANGO) closed at $8.58 in the latest trading session, marking no change from the prior day....…

AngioDynamics Shares Up on Breakthrough Device Designation

AngioDynamics Shares Up on Breakthrough Device Designation...…

AngioDynamics gets FDA breakthrough status for AngioVac indication

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AngioDynamics (ANGO) Gains As Market Dips: What You Should Know

In the latest trading session, AngioDynamics (ANGO) closed at $8.34, marking a +1.46% move from the previous day....…

Form 10-K ANGIODYNAMICS INC For: May 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ANGIODYNAMICS INC For: Jul 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AngioDynamics (ANGO) Q4 Earnings Lag Estimates, Revenues Top

AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in fourth-quarter fiscal 2023....…

AngioDynamics (ANGO) Lags Q4 Earnings Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of -33.33% and 0.37%, respectively, for the quarter ended May 2023. Do the…

AngioDynamics Issues Soft Fiscal 2024 Outlook

AngioDynamics Issues Soft Fiscal 2024 Outlook...…

AngioDynamics Posts 4Q Adj. Loss Amid Higher Costs

AngioDynamics Posts 4Q Adj. Loss Amid Higher Costs...…

AngioDynamics Non-GAAP EPS of $0.02 in-line, revenue of $91.1M beats by $0.66M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus…